These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 9278462

  • 1. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire.
    Simonneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R, Laurent M, Hirsch JL, Ferrari E, Bosson JL, Mottier D, Beau B.
    N Engl J Med; 1997 Sep 04; 337(10):663-9. PubMed ID: 9278462
    [Abstract] [Full Text] [Related]

  • 2. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism.
    Columbus Investigators, Büller HR, Gent M, Gallus AS, Ginsberg J, Prins MH, Baildon R.
    N Engl J Med; 1997 Sep 04; 337(10):657-62. PubMed ID: 9280815
    [Abstract] [Full Text] [Related]

  • 3. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV, CORTES Investigators. Clivarin: Assessment of Regression of Thrombosis, Efficacy, and Safety.
    N Engl J Med; 2001 Mar 01; 344(9):626-31. PubMed ID: 11228276
    [Abstract] [Full Text] [Related]

  • 4. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism.
    Büller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, van den Berg-Segers AE, Cariou R, Leeuwenkamp O, Lensing AW, Matisse Investigators.
    N Engl J Med; 2003 Oct 30; 349(18):1695-702. PubMed ID: 14585937
    [Abstract] [Full Text] [Related]

  • 5. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.
    Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau G.
    N Engl J Med; 1998 Feb 12; 338(7):409-15. PubMed ID: 9459643
    [Abstract] [Full Text] [Related]

  • 6. Incomplete recovery of lung perfusion after 3 months in patients with acute pulmonary embolism treated with antithrombotic agents. THESEE Study Group. Tinzaparin ou Heparin Standard: Evaluation dans l'Embolie Pulmonaire Study.
    Wartski M, Collignon MA.
    J Nucl Med; 2000 Jun 12; 41(6):1043-8. PubMed ID: 10855632
    [Abstract] [Full Text] [Related]

  • 7. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group.
    Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH.
    N Engl J Med; 1996 Mar 14; 334(11):682-7. PubMed ID: 8594426
    [Abstract] [Full Text] [Related]

  • 8. Low-molecular-weight heparin versus unfractionated heparin in the treatment of patients with acute pulmonary thromboembolism.
    Findik S, Erkan ML, Selçuk MB, Albayrak S, Atici AG, Doru F.
    Respiration; 2002 Mar 14; 69(5):440-4. PubMed ID: 12232452
    [Abstract] [Full Text] [Related]

  • 9. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV, Büller HR.
    Thromb Haemost; 2000 May 14; 83(5):652-6. PubMed ID: 10823256
    [Abstract] [Full Text] [Related]

  • 10. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.
    Quinlan DJ, McQuillan A, Eikelboom JW.
    Ann Intern Med; 2004 Feb 03; 140(3):175-83. PubMed ID: 14757615
    [Abstract] [Full Text] [Related]

  • 11. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P, Carnovali M, Marchiori A, Galilei Investigators.
    Arch Intern Med; 2004 May 24; 164(10):1077-83. PubMed ID: 15159264
    [Abstract] [Full Text] [Related]

  • 12. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
    Prescrire Int; 2013 Apr 24; 22(137):99-101, 103-4. PubMed ID: 23662321
    [Abstract] [Full Text] [Related]

  • 13. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
    Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M.
    N Engl J Med; 1996 Mar 14; 334(11):677-81. PubMed ID: 8594425
    [Abstract] [Full Text] [Related]

  • 14. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
    Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M, Fixed-Dose Heparin (FIDO) Investigators.
    JAMA; 2006 Aug 23; 296(8):935-42. PubMed ID: 16926353
    [Abstract] [Full Text] [Related]

  • 15. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.
    Dager WE, King JH, Branch JM, Chow SL, Ferrer RE, Pak S, Togioka PY, White RH.
    Ann Pharmacother; 2005 Aug 23; 39(7-8):1182-7. PubMed ID: 15956232
    [Abstract] [Full Text] [Related]

  • 16. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F, Julian JA, Kearon C.
    Thromb Haemost; 2001 Oct 23; 86(4):980-4. PubMed ID: 11686355
    [Abstract] [Full Text] [Related]

  • 17. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease.
    Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, Elias D, Grigg A, Musset D, Rodgers GM, Trowbridge AA, Yusen RD, Zawilska K, Enoxaparin Clinical Trial Group.
    Ann Intern Med; 2001 Feb 06; 134(3):191-202. PubMed ID: 11177331
    [Abstract] [Full Text] [Related]

  • 18. Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparin.
    Riess H, Becker LK, Melzer N, Harenberg J.
    Blood Coagul Fibrinolysis; 2014 Dec 06; 25(8):838-44. PubMed ID: 25004024
    [Abstract] [Full Text] [Related]

  • 19. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M, Demers C, Gurfinkel EP, Turpie AG, Fromell GJ, Goodman S, Langer A, Califf RM, Fox KA, Premmereur J, Bigonzi F.
    N Engl J Med; 1997 Aug 14; 337(7):447-52. PubMed ID: 9250846
    [Abstract] [Full Text] [Related]

  • 20. Outpatient treatment of pulmonary embolism with dalteparin.
    Kovacs MJ, Anderson D, Morrow B, Gray L, Touchie D, Wells PS.
    Thromb Haemost; 2000 Feb 14; 83(2):209-11. PubMed ID: 10739374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.